XML 22 R33.htm IDEA: XBRL DOCUMENT v2.4.1.9
Acquisition and Stockholders' Equity (Deficit) (Details 2) (Callisto)
0 Months Ended
Jan. 17, 2013
Oct. 15, 2012
Jan. 17, 2013
Oct. 15, 2012
Oct. 14, 2012
Callisto
         
Acquisition and Stockholders' Equity (Deficit)          
Shares issued in connection with merger 28,605,379us-gaap_StockIssuedDuringPeriodSharesAcquisitions
/ us-gaap_BusinessAcquisitionAxis
= sgyp_CallistoPharmaceuticalsIncMember
       
Exchange Ratio of shares 0.1799sgyp_ExchangeRatioOfShares
/ us-gaap_BusinessAcquisitionAxis
= sgyp_CallistoPharmaceuticalsIncMember
0.1799sgyp_ExchangeRatioOfShares
/ us-gaap_BusinessAcquisitionAxis
= sgyp_CallistoPharmaceuticalsIncMember
0.1799sgyp_ExchangeRatioOfShares
/ us-gaap_BusinessAcquisitionAxis
= sgyp_CallistoPharmaceuticalsIncMember
0.1799sgyp_ExchangeRatioOfShares
/ us-gaap_BusinessAcquisitionAxis
= sgyp_CallistoPharmaceuticalsIncMember
0.17sgyp_ExchangeRatioOfShares
/ us-gaap_BusinessAcquisitionAxis
= sgyp_CallistoPharmaceuticalsIncMember
Cancellation of stock (in shares) 22,294,976us-gaap_StockRepurchasedAndRetiredDuringPeriodShares
/ us-gaap_BusinessAcquisitionAxis
= sgyp_CallistoPharmaceuticalsIncMember
       
Lock-up period 24 months 24 months      
Shares granted in connection with merger 1,221,316us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
/ us-gaap_BusinessAcquisitionAxis
= sgyp_CallistoPharmaceuticalsIncMember